We are live on ! Find out more
TDOC icon

Teladoc Health

365 hedge funds and large institutions have $1.15B invested in Teladoc Health in 2024 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 85 increasing their positions, 130 reducing their positions, and 95 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

26% more call options, than puts

Call options by funds: $60.8M | Put options by funds: $48.2M

8.59% less ownership

Funds ownership: 81.93%73.33% (-8.6%)

10% less funds holding

Funds holding: 405365 (-40)

15% less capital invested

Capital invested by funds: $1.36B → $1.15B (-$207M)

35% less repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 130

39% less first-time investments, than exits

New positions opened: 58 | Existing positions closed: 95

Holders
365
Holders Change
-40
Holders Change %
-9.88%
% of All Funds
5.24%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
58
Increased
85
Reduced
130
Closed
95
Calls
$60.8M
Puts
$48.2M
Net Calls
+$12.6M
Net Calls Change
+$14.7M
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
26
UBS Group
Switzerland
$9.7M -$3.78M -456,423 -30%
CSS
27
Cubist Systematic Strategies
Connecticut
$9.25M -$2.56M -308,770 -23%
Deutsche Bank
28
Deutsche Bank
Germany
$8.86M +$6.04M +729,227 +309%
MAM
29
Monaco Asset Management
Monaco
$7.99M +$6.17M +745,791 +597%
N
30
Nuveen
North Carolina
$7.99M +$2.38M +287,931 +49%
Qube Research & Technologies (QRT)
31
Qube Research & Technologies (QRT)
United Kingdom
$6.63M -$7.81M -943,227 -57%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$6.62M -$3.32M -401,000 -36%
UBS AM
33
UBS AM
Illinois
$6.3M -$1.68M -202,586 -23%
AllianceBernstein
34
AllianceBernstein
Tennessee
$6.02M +$3.44M +415,575 +173%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$5.69M -$2.45M -296,565 -32%
Citadel Advisors
36
Citadel Advisors
Florida
$5.63M +$4.22M +510,012 +496%
Robeco Institutional Asset Management
37
Robeco Institutional Asset Management
Netherlands
$5.28M +$2.79M +337,305 +142%
LCM
38
Lakewood Capital Management
New York
$5.28M +$4.76M +575,000 New
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$5.04M -$392K -47,390 -8%
CC
40
Clearline Capital
New York
$4.77M -$31.8M -3,844,861 -88%
Capital Fund Management (CFM)
41
Capital Fund Management (CFM)
France
$4.34M +$1.33M +160,176 +51%
Tudor Investment Corp
42
Tudor Investment Corp
Connecticut
$4.04M +$3.64M +440,001 New
AQR Capital Management
43
AQR Capital Management
Connecticut
$4.02M -$1.79M -216,802 -32%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$3.94M -$189K -22,869 -5%
Marshall Wace
45
Marshall Wace
United Kingdom
$3.62M +$3.26M +394,133 New
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$3.4M -$14.3M -1,731,303 -82%
Massachusetts Financial Services
47
Massachusetts Financial Services
Massachusetts
$3.4M +$2.53M +305,961 +477%
HSBC Holdings
48
HSBC Holdings
United Kingdom
$3.36M -$217K -26,248 -7%
Citigroup
49
Citigroup
New York
$3.3M -$1.27M -153,712 -30%
Swiss National Bank
50
Swiss National Bank
Switzerland
$3.06M

TDOC Hedge Fund Activity: Q3 2024 in Review

365 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q3 2024, worth a combined $1.15B — down 15% from $1.36B a quarter earlier.

Sellers outnumbered buyers: 95 funds closed out of TDOC and 58 opened new positions — a net loss of 37 holders — while 130 trimmed existing stakes and 85 added.

The largest buyer was Goldman Sachs, adding an estimated $45M. The largest seller was ARK Investment Management, exiting entirely with an estimated $61.9M sold.

  • 365 institutional investors held Teladoc Health (TDOC) as of Q3 2024, down from 405 in Q2 2024.
  • Funds reported $1.15B of Teladoc Health stock for Q3 2024, down 15% quarter-over-quarter.
  • 58 funds opened new Teladoc Health positions in Q3 2024 and 95 closed out, a net change of -37 holders.
  • The largest Teladoc Health buyer in Q3 2024 was Goldman Sachs, an estimated $45M added.
  • The largest Teladoc Health seller in Q3 2024 was ARK Investment Management, an estimated $61.9M sold.

Based on aggregated 13F filings for Q3 2024.